Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)

NCT07428499 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema (HAE)
Hereditary Angioedema - Type 1
Hereditary Angioedema - Type 2
HAE

Interventions

DRUG: ADX-324 Dose Level 1
DRUG: ADX-324 Dose Level 2

Sponsor

ADARx Pharmaceuticals, Inc.